Fasolino, G.; Awada, G.; Moschetta, L.; Koulalis, J.S.; Neyns, B.; Verhelst, B.; Van Elderen, P.; Nelis, P.; de Lichtbuer, P.C.; Cools, W.;
et al. Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study. J. Clin. Med. 2023, 12, 1214.
https://doi.org/10.3390/jcm12031214
AMA Style
Fasolino G, Awada G, Moschetta L, Koulalis JS, Neyns B, Verhelst B, Van Elderen P, Nelis P, de Lichtbuer PC, Cools W,
et al. Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study. Journal of Clinical Medicine. 2023; 12(3):1214.
https://doi.org/10.3390/jcm12031214
Chicago/Turabian Style
Fasolino, Giuseppe, Gil Awada, Laura Moschetta, Jorgos Socrates Koulalis, Bart Neyns, Bert Verhelst, Peter Van Elderen, Pieter Nelis, Paul Cardon de Lichtbuer, Wilfried Cools,
and et al. 2023. "Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study" Journal of Clinical Medicine 12, no. 3: 1214.
https://doi.org/10.3390/jcm12031214
APA Style
Fasolino, G., Awada, G., Moschetta, L., Koulalis, J. S., Neyns, B., Verhelst, B., Van Elderen, P., Nelis, P., de Lichtbuer, P. C., Cools, W., & Ten Tusscher, M.
(2023). Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study. Journal of Clinical Medicine, 12(3), 1214.
https://doi.org/10.3390/jcm12031214
